Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Center for Psychedelic Drug Research and Education
Other

Center for Psychedelic Drug Research and Education

Tracked across 1 events · 6 articles · First seen Jul 30, 2026 · Last active Jul 31, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 70
Tech
Psilocybin Therapy Trial for Veterans PTSD
The first U.S. clinical trial of psilocybin-assisted therapy in veterans with severe, treatment-resistant PTSD demonstrated safety and promising efficacy. In the pilot study of 12 veterans, 75% achieved remission one month after treatment, with no…
Impact: Led the study, establishing itself as a key research center in psychedelic therapy, which may increase its influence and funding opportunities.
Jul 30, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Center for Psychedelic Drug Research and Education live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.